ICD-10 Coding for Angiolipoma(D17.0, D17.1, D17.21)
Learn about the ICD-10 coding for angiolipoma, including site-specific codes, documentation requirements, and differentiation from other lipomatous neoplasms.
Complete code families applicable to Angiolipoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D17.9 | Benign lipomatous neoplasm, unspecified | Use when angiolipoma is documented without site specificity. |
|
| D17.21 | Benign lipomatous neoplasm of skin and subcutaneous tissue of right arm | Use when angiolipoma is documented on the right arm. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutAngiolipoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Angiolipoma.
Documenting 'lipoma' without specifying 'angiolipoma'
Impact
Clinical: Misrepresentation of the condition, Regulatory: Non-compliance with coding standards, Financial: Potential for incorrect billing
Mitigation
Educate providers on the importance of specificity, Implement checklists for documentation
Coding as 'lipoma' without vascular documentation
Impact
Reimbursement: Potential underpayment due to incorrect code usage., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Query provider for confirmation of vascular components.
Unspecified site coding
Impact
Using D17.9 without site specificity can trigger audits.
Mitigation
Ensure documentation includes specific site information.